FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385705872> ?p ?o ?g. }

• W4385705872 endingPage "e55181bb" @default.
• W4385705872 startingPage "e55181bb" @default.
• W4385705872 abstract "Topic: 20. Lymphoma Biology & Translational Research Background: Follicular lymphoma (FL) is an incurable type of B-cell malignancy that accounts for 25 percent of all lymphomas. Although most patients achieve remission with immuno-chemotherapy, almost all of them will experience multiple relapses after treatment. The prognosis is especially poor for around 20 percent of FL patients who relapse within two years after treatment initiation. The understanding of the heterogeneity of treatment responses is limited by the absence of in vitro or in vivo experimental models, mainly due to the strong dependence of tumor cells on their surrounding environment to survive. Aims: This project aimed to develop a primary FL cell xenograft model in chicken embryos to capture treatment response heterogeneity and analyze the mechanisms of response to immune-chemotherapy. Methods: The FL-AVI-PDXTM model was developed by transplanting primary FL cells into chicken embryos. We transplanted 20 biopsy samples, including good (n=11) and poor clinical responders (POD24, n=9), and treated each set of embryos with either RCHOP or vehicle intravenously. The effects of treatment were evaluated 24 hours later with tumor volume measurement by light-sheet microscopy and transcriptomic analysis at the single-cell level (scRNAseq). Results: All samples engrafted successfully in the aorto-gonado-mesonephros of chicken embryos. Tumor volume reduction achieved with RCHOP in the avian embryo was strongly correlated to patient’s clinical outcome (mean tumor volume decreased by 35% in the good responders (n=11) compared to an increase of 2% in the poor responders (n = 9), p < 0.05). Transcriptomic analysis of individual cells was conducted on 14 patients in three different conditions (before and after transplantation with RCHOP or vehicle treatment). We found a robust signature of 21 genes whose expression increased after exposure to RCHOP in all the patients. Among these genes was BAX, a key effector of the mitochondrial outer membrane permeabilization (MOMP), whose inactivation (by CRISPR-CAS9) conferred resistance to RCHOP in cell lines. Furthermore, Venetoclax, a BCL2 inhibitor that lowers the threshold of BAX level required for MOMP, had synergistic effects with RCHOP in cell lines and primary samples in vivo, validating the findings in the model. Summary/Conclusion: FL-AVI-PDXTM enables to study primary FL samples, and to capture the heterogeneity of clinical response to a complex therapeutic regimen. Moreover, it provides a unique opportunity to analyze the mechanisms of response to immune-chemotherapy and to identify therapeutic targets (such as BAX) that can be functionally assessed in the avian embryo.Keywords: Chemotherapy, Animal model, Follicular lymphoma, RNA-seq" @default.
• W4385705872 created "2023-08-10" @default.
• W4385705872 creator A5004594498 @default.
• W4385705872 creator A5011058157 @default.
• W4385705872 creator A5013626858 @default.
• W4385705872 creator A5027657054 @default.
• W4385705872 creator A5031212436 @default.
• W4385705872 creator A5034948751 @default.
• W4385705872 creator A5040687539 @default.
• W4385705872 creator A5047139655 @default.
• W4385705872 creator A5051461864 @default.
• W4385705872 creator A5075530519 @default.
• W4385705872 creator A5081115538 @default.
• W4385705872 creator A5082659815 @default.
• W4385705872 creator A5082733287 @default.
• W4385705872 creator A5086354986 @default.
• W4385705872 creator A5087531191 @default.
• W4385705872 date "2023-08-01" @default.
• W4385705872 modified "2023-10-18" @default.
• W4385705872 title "P1243: FUNCTIONAL PRECISION ONCOLOGY FOR FOLLICULAR LYMPHOMA WITH PATIENT-DERIVED XENOGRAFT IN AVIAN EMBRYOS." @default.
• W4385705872 doi "https://doi.org/10.1097/01.hs9.0000971864.55181.bb" @default.
• W4385705872 hasPublicationYear "2023" @default.
• W4385705872 type Work @default.
• W4385705872 citedByCount "0" @default.
• W4385705872 crossrefType "journal-article" @default.
• W4385705872 hasAuthorship W4385705872A5004594498 @default.
• W4385705872 hasAuthorship W4385705872A5011058157 @default.
• W4385705872 hasAuthorship W4385705872A5013626858 @default.
• W4385705872 hasAuthorship W4385705872A5027657054 @default.
• W4385705872 hasAuthorship W4385705872A5031212436 @default.
• W4385705872 hasAuthorship W4385705872A5034948751 @default.
• W4385705872 hasAuthorship W4385705872A5040687539 @default.
• W4385705872 hasAuthorship W4385705872A5047139655 @default.
• W4385705872 hasAuthorship W4385705872A5051461864 @default.
• W4385705872 hasAuthorship W4385705872A5075530519 @default.
• W4385705872 hasAuthorship W4385705872A5081115538 @default.
• W4385705872 hasAuthorship W4385705872A5082659815 @default.
• W4385705872 hasAuthorship W4385705872A5082733287 @default.
• W4385705872 hasAuthorship W4385705872A5086354986 @default.
• W4385705872 hasAuthorship W4385705872A5087531191 @default.
• W4385705872 hasBestOaLocation W43857058721 @default.
• W4385705872 hasConcept C126322002 @default.
• W4385705872 hasConcept C142724271 @default.
• W4385705872 hasConcept C143998085 @default.
• W4385705872 hasConcept C16685009 @default.
• W4385705872 hasConcept C196843134 @default.
• W4385705872 hasConcept C2775934546 @default.
• W4385705872 hasConcept C2776694085 @default.
• W4385705872 hasConcept C2777058707 @default.
• W4385705872 hasConcept C2779338263 @default.
• W4385705872 hasConcept C502942594 @default.
• W4385705872 hasConcept C71924100 @default.
• W4385705872 hasConcept C86803240 @default.
• W4385705872 hasConcept C95444343 @default.
• W4385705872 hasConceptScore W4385705872C126322002 @default.
• W4385705872 hasConceptScore W4385705872C142724271 @default.
• W4385705872 hasConceptScore W4385705872C143998085 @default.
• W4385705872 hasConceptScore W4385705872C16685009 @default.
• W4385705872 hasConceptScore W4385705872C196843134 @default.
• W4385705872 hasConceptScore W4385705872C2775934546 @default.
• W4385705872 hasConceptScore W4385705872C2776694085 @default.
• W4385705872 hasConceptScore W4385705872C2777058707 @default.
• W4385705872 hasConceptScore W4385705872C2779338263 @default.
• W4385705872 hasConceptScore W4385705872C502942594 @default.
• W4385705872 hasConceptScore W4385705872C71924100 @default.
• W4385705872 hasConceptScore W4385705872C86803240 @default.
• W4385705872 hasConceptScore W4385705872C95444343 @default.
• W4385705872 hasIssue "S3" @default.
• W4385705872 hasLocation W43857058721 @default.
• W4385705872 hasLocation W43857058722 @default.
• W4385705872 hasOpenAccess W4385705872 @default.
• W4385705872 hasPrimaryLocation W43857058721 @default.
• W4385705872 hasRelatedWork W1501529729 @default.
• W4385705872 hasRelatedWork W1978208370 @default.
• W4385705872 hasRelatedWork W2040879484 @default.
• W4385705872 hasRelatedWork W2132729361 @default.
• W4385705872 hasRelatedWork W2183685009 @default.
• W4385705872 hasRelatedWork W2185614907 @default.
• W4385705872 hasRelatedWork W2418980378 @default.
• W4385705872 hasRelatedWork W2460378076 @default.
• W4385705872 hasRelatedWork W2598336924 @default.
• W4385705872 hasRelatedWork W3158680495 @default.
• W4385705872 hasVolume "7" @default.
• W4385705872 isParatext "false" @default.
• W4385705872 isRetracted "false" @default.
• W4385705872 workType "article" @default.